Chemed Corporation

US$528.05As of Sun 8 Nov 2026, 12:00 UTC
NYSE:CHEHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 14.48%
Div yield 0.53%
ROE 29.14%
Medical Care Facilities
Beta (5Y) 0.49
PE TTM 25.23
TSR TTM 23.09%
Mkt cap US$6.844B
ROIC 24.58%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$570
7.93%
(46.40%)
Hold 12|12|11|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share$
5.77
5.49
6.06
5.76
8.19%
7.08%
10.00%
2.33%
Revenue$M
789.5
829.2
816.1
806.8
10.61%
13.06%
6.46%
(0.13%)
Peers (US$6.844B)
Cap (US$)
PE
7.873B
28.21x
5.342B
25.51x
5.235B
77.36x
Capital
TTM
5Y
10Y
Leveragex
6.460
(0.055)
(0.053)
EBIT/Intx
1.142
0.114
0.112
Own earn%
282.74
(56.16)
(55.60)
Sh yield%
20.44
37.57
41.10
Owners
Insiders/Inst%
14.64
87.72
Short interest%
2.66
SBC / revenue%
1.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
17–20
$1 testx
—
Incr. ROIC%
88